A three-day meeting on the Convention on Biological Diversity that just wrapped up in Rome will go down in history as a ...

Neuroscience specialist Harmony Biosciences has agreed to acquire Zynerba, adding its cannabidiol (CBD) gel product Zygel for Fragile X syndrome and other rare neuropsychiatric disorders to its ...

The Pennsylvania-based drugmaker expects between $820 million and $860 million this year from WAKIX, as it pushes its ...